Over 2,000 real rulings β analysed for what they mean to your team. Published every day.
Showing 1914 cases
Complaint said a Trixeo HCP eligibility checklist omitted SmPC counselling/stop-treatment text for acute narrow-angle glaucoma. Panel found breaches, but Appeal Board overturned:…
PMCPA ruled GSKβs Zejula βPRIMA AE managementβ webpage misleading for implying AEs could be managed by dose interruption/modification without highlighting when SmPC…
Anonymous ex-employee alleged Moderna misused preprint vaccine effectiveness data, cherry-picked graphs and sought UK contract advantage via JCVI presentations. Panel found no…
A UK-based GSK Global employee βcelebratedβ a third-party LinkedIn post about promising niraparib results in glioblastoma. PMCPA found promotion to the public…
A pharmacist complained about a repβs claim that NICE said infliximab SC fell under infliximab IV TAG due to cost neutrality. Panel…
Complaint alleged Jemperli HCP webpages werenβt properly certified for mobile due to layout/navigation differences and that a βmanageable safety profileβ claim was…
Complaint alleged a Trelegy Ellipta rotating banner promoted an unlicensed switch from three inhalers (incl. SABA). PMCPA Panel found no breach of…
A hospital pharmacist complained about a Pfizer-authorised letter asking hospitals to add Ecalta and Celsentri to electronic prescribing/dispensing systems. The Panel ruled…
A PCT pharmacist alleged a Clenil cost-comparison chart was misleading because it omitted 200mcg data. The Panel found the Scottish Drug Tariff…
A letter about the UK HPV vaccine tender was ruled promotional for Gardasil, lacked prescribing information and adverse event reporting guidance, and…
Complaint about Lantus promotional leavepieces and a mailer. Issues included β24-hour efficacyβ wording and comparative hypoglycaemia claims based on pooled observational data.…
A GP complained that a Toviaz ad also promoted tolterodine without prescribing information. The Panel ruled a breach for missing obligatory information,…
A journal-lookalike supplement reporting a company-run symposium was presented as a sponsored independent forum report. The Panel ruled it was disguised promotion,…
A Champix journal ad claimed significantly greater quit success vs NiQuitin patch. PMCPA ruled the claim misleading because the ad didnβt explain…
A respiratory nurse complained about a sales managerβs personal Facebook/Instagram posts referencing a nurse KOL. Panel found one Instagram post in scope…
Anzal, our PMCPA rulings expert, has knowledge of over 2,000 published cases β ask about precedents, clauses, and how they apply to your situation.
One real case. One key lesson. Every week β free.